Tissue Typing for Cadaveric Transplantation
In March 1969 a collaborative scheme which eventually involved 22 hospitals in the United Kingdom and Eire was established as 'The London Transplant Group'. The Transplantation Immunology Unit of the London Hospital Medical College acted as the coordinating centre (Festenstein et al. 1969 . The objectives were to improve the HL-A matching of donors and recipients of renal transplants and to assess the influence of the HL-A system on graft survival. The preliminary results of this investigation over the first 18 months are presented in this communication.
The cadaver kidneys transplanted during this period totalled 162. The donors and recipients were tissue typed for 16-22 HL-A antigens by microlymphocytotoxicity techniques. Blood group and tissue typing information on the patients from the cooperating centres was stored on tape for use on the Elliot 803 computer at The London Hospital. The best available recipients for any given donor were selected and arrangements made for transfer to the recipients of the cadaver kidneys. If no suitably matched recipient was found reference was made to Eurotransplant (Leiden), Scandiatransplant (Arhus), and Francetransplant (Paris). Results: Of the original 162 transplants, 128 patients were able to rely completely on their transplanted kidneys without recourse to dialysis for at least 7 days after transplant. Of these patients, 39 received well matched transplants (i.e. had 3 or 4 antigens in common, designated Groups '3' and '4'), 50 received 'poorly matched' transplants (i.e. 0, 1 or 2 donor antigens in common with the recipients, net histocompatibility ratio (Rapaport & Dausset 1970 ) -NHR <0-361, designated Group 2B). A further 39 patients received slightly better matched kidneys (1 or 2 antigens in common NHR 0-361-0-66, designated Group 2A). The assessment of the influence of HL-A matching on transplant survival was made over a six-month post-transplant period. In the well matched group all those completely matched for 4 HL-A antigens had functioning kidneys; of those patients with 3 antigens in common (one definite or possible incompatibility) the actuarial fraction surviving was 0-83, In Group 2B, the actuarial fraction surviving was 0 59, and in Group 2A, 0-68. Although these results are statistically significant (well matched (Groups 3 and 4) versus poorly matched (Group 2B)-P <0 01), a more prolonged follow-up period is required to establish whether this level of matching is sufficient to prevent late chronic rejection. It is accordingly felt that collaborative schemes such as this are worthwhile, especially since more than 50% of the recent transplants were carried out at the superior level of matching.
[The data presented here are abstracted from 
Renal Preservation
During the last few years, a cooperative scheme has be-n developed in Northern Europe, to try to eliminate wastage of donor kidneys by providing a greater number of possible recipients, and to endeavour to obtain more accurate matching of donor and recipient tissues. The transport of such kidneys, even over relatively short distances in the United Kingdom, remains a problem, as the chances of return of function to the donor kidney depend, among other
